Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193,980 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer/testis antigens: from serology to mRNA cancer vaccine.
Fan C, Qu H, Wang X, Sobhani N, Wang L, Liu S, Xiong W, Zeng Z, Li Y. Fan C, et al. Among authors: wang x, wang l. Semin Cancer Biol. 2021 Nov;76:218-231. doi: 10.1016/j.semcancer.2021.04.016. Epub 2021 Apr 25. Semin Cancer Biol. 2021. PMID: 33910064 Review.
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.
Huang Q, Xia J, Wang L, Wang X, Ma X, Deng Q, Lu Y, Kumar M, Zhou Z, Li L, Zeng Z, Young KH, Yi Q, Zhang M, Li Y. Huang Q, et al. Among authors: wang x, wang l. J Hematol Oncol. 2018 Apr 23;11(1):58. doi: 10.1186/s13045-018-0600-x. J Hematol Oncol. 2018. PMID: 29685162 Free PMC article.
Targeting the IDO1 pathway in cancer: from bench to bedside.
Liu M, Wang X, Wang L, Ma X, Gong Z, Zhang S, Li Y. Liu M, et al. Among authors: wang x, wang l. J Hematol Oncol. 2018 Aug 2;11(1):100. doi: 10.1186/s13045-018-0644-y. J Hematol Oncol. 2018. PMID: 30068361 Free PMC article. Review.
Mutant p53 as an Antigen in Cancer Immunotherapy.
Sobhani N, D'Angelo A, Wang X, Young KH, Generali D, Li Y. Sobhani N, et al. Among authors: wang x. Int J Mol Sci. 2020 Jun 8;21(11):4087. doi: 10.3390/ijms21114087. Int J Mol Sci. 2020. PMID: 32521648 Free PMC article. Review.
MR1-Restricted T Cells in Cancer Immunotherapy.
Flores-Villanueva P, Sobhani N, Wang X, Li Y. Flores-Villanueva P, et al. Among authors: wang x. Cancers (Basel). 2020 Aug 3;12(8):2145. doi: 10.3390/cancers12082145. Cancers (Basel). 2020. PMID: 32756356 Free PMC article. Review.
Targeting PD-L1 in non-small cell lung cancer using CAR T cells.
Liu M, Wang X, Li W, Yu X, Flores-Villanueva P, Xu-Monette ZY, Li L, Zhang M, Young KH, Ma X, Li Y. Liu M, et al. Among authors: wang x. Oncogenesis. 2020 Aug 13;9(8):72. doi: 10.1038/s41389-020-00257-z. Oncogenesis. 2020. PMID: 32792499 Free PMC article.
193,980 results
You have reached the last available page of results. Please see the User Guide for more information.